Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KF-0210 vs celecoxib in knee osteoarthritis (Phase II, China)
CTR20253495Phase 2Completed
- Sponsor
- Caref Pharmaceuticals
- Start
- Sep 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of KF-0210 in knee osteoarthritis (OA), sponsored by Caref Pharmaceuticals. Started Sep 2025; status: completed.
02
Drugs
KF-0210
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on CTR20253495.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20253495.